The regulatory cytokine IL-10 is significantly lower in dilated cardiomyopathy compared to ischemic heart disease, suggesting a distinct autoimmune pathogenesis in DCM.
Answers are grounded in this paper and cite their sources.
May indicate distinct autoimmune features in DCM; leaves open immunomodulatory targets pending prospective validation.
OBJECTIVES: To investigate whether cytokine patterns differ with respect to heart failure (HF) etiology, and to study how cytokine concentrations relate to hemodynamic alterations. METHODS: Plasma levels of interleukin-6 (IL-6), interleukin-10 (IL-10), tumor necrosis factor alpha (TNF-alpha) and high sensitive-CRP (hs-CRP) were analysed with enzyme-linked-immunosorbent serologic assay and turbidimetry in 45 healthy subjects and 89 patients with HF, of whom 65 were diagnosed with dilated cardiomyopathy (DCM) and 24 had ischemic heart disease (IHD). RESULTS: IL-6, IL-10 and hs-CRP were significantly higher in patients with HF as compared to healthy controls. The IL-10 was significantly lower in patients with DCM as compared to IHD, also when adjusting for clinical variables. Diastolic filling pressure correlated with IL-6, IL-10 and hs-CRP while heart rate (HR) correlated with IL-6 and TNF-alpha. CONCLUSIONS: Proinflammatory cytokines are elevated in patients with HF and display a positive correlation with filling pressures and HR. Most significant, the regulatory and protective cytokine IL-10 was much lower in patients with DCM as compared to IHD, indicating a differentiation in cytokine patterns with respect to HF etiology.
No takes yet. Share an insight, caveat, or question.
Lindberg et al. (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: